A share price of Cabaletta Bio Inc [CABA] is currently trading at $2.85, down -1.04%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CABA shares have gain 22.84% over the last week, with a monthly amount glided 30.73%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Evercore ISI downgraded its rating to In-line on December 20, 2024, and dropped its price target to $6. On December 19, 2024, downgrade downgraded it’s rating to Equal Weight and revised its price target to $6 on the stock. UBS started tracking the stock assigning a Buy rating and suggested a price target of $10 on October 10, 2024. Jefferies initiated its recommendation with a Buy and recommended $36 as its price target on February 05, 2024. William Blair started tracking with a Outperform rating for this stock on November 29, 2023, and assigned it a price target of $38. In a note dated October 24, 2023, Cantor Fitzgerald initiated an Overweight rating and provided a target price of $40 on this stock.
Cabaletta Bio Inc experienced fluctuations in its stock price throughout the past year between $0.99 and $5.46. Currently, Wall Street analysts expect the stock to reach $16.33 within the next 12 months. Cabaletta Bio Inc [NASDAQ: CABA] shares were valued at $2.85 at the most recent close of the market. An investor can expect a potential return of 472.98% based on the average CABA price forecast.
Analyzing the CABA fundamentals
Gross Profit Margin for this corporation currently stands at -0.34% with Operating Profit Margin at -91.5%, Pretax Profit Margin comes in at -88.09%, and Net Profit Margin reading is -88.09%. To continue investigating profitability, this company’s Return on Assets is posted at -0.64, Equity is -0.92 and Total Capital is -0.82. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.77 points at the first support level, and at 2.69 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.93, and for the 2nd resistance point, it is at 3.01.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Cabaletta Bio Inc [NASDAQ:CABA] is 4.78. As well, the Quick Ratio is 4.78, while the Cash Ratio is 3.51.
